Embla Medical hf

EMBLA.CO · Health Technology · Medical Specialties · IS

3,449 employees · ossur.com/corporate

About

Ossur hf is an Icelandic company specializing in the development and manufacturing of orthopedic products. The company was founded in 1971 by Orn Ragnarsson and has since brought many innovative products to the market. The company is headquartered in Reykjavik, Iceland, and operates in more than 30 countries worldwide. Furthermore, the company collaborates with partners and distributors from around the world. Ossur's products are intended for people with amputations, injuries, or chronic pain. Ossur's business model is to develop and manufacture high-quality, innovative solutions for the orthopedic industry. Ossur's products aim to improve the mobility, comfort, and quality of life for people with disabilities and injuries. Ossur operates in three main divisions: prosthetics, braces, and motion analysis. The prosthetics division focuses on the development of artificial limbs for people who have undergone amputation. The braces division focuses on the development of products such as knee braces, back braces, and ankle braces to support people with injuries or chronic pain. The motion analysis division focuses on the development of products such as motion measurement systems and gait analysis devices to assist orthopedic experts in diagnosing and treating patients. One of Ossur's most well-known products is the "Flex-Foot" leg prosthesis. The design of this prosthesis is based on the natural movements of a human foot and is a milestone in prosthetic development. Another innovative product from Ossur is the "Rheo" knee joint system, which is based on artificial intelligence and allows the user to walk more naturally. In recent years, Ossur has also expanded its product portfolio to the field of sports. The company has developed a range of products to help athletes improve their performance, avoid injuries, and heal faster. Overall, Ossur has shown in recent years that the company is always looking for new opportunities to develop innovative solutions in the field of orthopedics. Through a focus on research and development and collaboration with leading orthopedic experts, Ossur has established itself as a key player in the market.

Annual results

Reported figures, USD · revenue up 12.8% in 2025

YearRevenueNet incomeNet marginFree cash flow
2025963M86.0M8.9%—
2024854M68.0M8.0%—
2023799M58.0M7.3%—
2022718M42.0M5.8%—
2021718M63.0M8.8%—

Dividends per share

2020 0.15 USD2019 0.14 USD2018 0.13 USD2017 0.12 USD2016 0.12 USD

EMBLA.CO in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Embla Medical hf are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Embla Medical hf (EMBLA.CO) — company profile and financials · MarketPulse